Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Gabriela Torres Pérez-Solero"'
Autor:
Pilar García-Alfonso, Andrés Jesús Muñoz Martín, Laura Ortega Morán, Javier Soto Alsar, Gabriela Torres Pérez-Solero, Montserrat Blanco Codesido, Pilar Aitana Calvo Ferrandiz, Silvina Grasso Cicala
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Colorectal cancer (CRC) is one of the most common forms of cancer, with an estimated 1.36 million new cases and almost 700,000 deaths annually. Approximately 21% of patients with CRC have metastatic disease at diagnosis. The objective of this article
Externí odkaz:
https://doaj.org/article/344cd31c70874b66a91affaa308d000e
Autor:
Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Rocío Martín Lozano, Manuel Alva Bianchi, Mónica Benavente de Lucas, María Palma Gómez, Marc Ariant Cañete Muñoz, Bárbara Lobato Delgado, Victoria Tirado Anula, Blanca Morón García, Magdalena Ruiz Zamorano, Ivan Marquez-Rodas, Isabel Echavarria Diaz Guardamino, Gabriela Torres Pérez-Solero, Aitana Calvo Ferrándiz, Laura Ortega, Jose Manuel Soria, Pilar Garcia-Alfonso, Miguel Martin, Andrés J. Muñoz Martín
Publikováno v:
Journal of Clinical Oncology. 41:670-670
670 Background: Pancreatic Ductal Adenocarcinoma (PDAC) has historically been an important diagnostic and therapeutic challenge. The multidisciplinary approach and new diagnostic techniques’ implementation have modified this process. Methods: We co
Autor:
Javier Soto, Marianela Bringas, Natalia Gutiérrez Alonso, Andrés J. Muñoz Martín, Aitana Calvo Ferrándiz, Gabriela Torres Pérez-Solero, Laura Ortega, Rocío Martín Lozano, Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Carlos López Jiménez, Ana Gutierrez Ortiz de la Tabla, David Salomon Juliao Caamaño, Marc Ariant Cañete Muñoz, Mónica Benavente de Lucas, María Palma Gómez, Manuel Alva Bianchi, Íñigo Martínez Delfrade, Miguel Martin, Pilar Garcia-Alfonso
Publikováno v:
Journal of Clinical Oncology. 41:66-66
66 Background: Patients with mCRC harboring BRAF mutation have worse prognosis and poor outcomes. However, those who have resectable metastatic disease and undergo surgery may have better outcomes compared to those who do not. Differences in clinical
Autor:
Marianela Bringas, Javier Soto, Natalia Gutiérrez Alonso, Andrés J. Muñoz Martín, Aitana Calvo Ferrándiz, Gabriela Torres Pérez-Solero, Laura Ortega, Rocío Martín Lozano, Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Ana Gutierrez Ortiz de la Tabla, Carlos López Jiménez, David Salomon Juliao Caamaño, María Palma Gómez, Mónica Benavente de Lucas, Marc Ariant Cañete Muñoz, Manuel Alva Bianchi, Íñigo Martínez Delfrade, Miguel Martin, Pilar Garcia-Alfonso
Publikováno v:
Journal of Clinical Oncology. 41:159-159
159 Background: Peritoneal metastases in patients with mCRC are commonly associated with poor outcomes. Some of these patients are candidates to undergo metastases surgery, which may result in better prognosis; however, clinical and molecular charact
Autor:
Rocío Martín Lozano, Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Bárbara Lobato Delgado, María Palma Gómez, Marc Ariant Cañete Muñoz, Mónica Benavente de Lucas, Carlos López Jiménez, Victoria Tirado Anula, Blanca Morón García, María de Toro Carmena, Marianela Bringas Beranek, Javier Soto Alsar, Gabriela Torres Pérez-Solero, Aitana Calvo, Laura Ortega, Jose Manuel Soria, Pilar Garcia-Alfonso, Miguel Martin, Andrés J. Muñoz Martín
Publikováno v:
Journal of Clinical Oncology. 41:740-740
740 Background: Several inflammatory scores such as the Systemic Inflammation Response Index (SIRI), the Inflammation Index Score (IIS), and the Neutrophil Lymphocyte Ratio (NLR) have been reported to have prognostic value in PDAC with different resu
Autor:
Pilar Garcia-Alfonso, Natalia Gutiérrez Alonso, Marianela Bringas Beranek, Javier Soto Alsar, Carlos López Jiménez, Ana Gutierrez Ortiz de la Tabla, Roberto Jiménez Rodríguez, Rocío Martín Lozano, César Gutiérrez Pérez, Manuel Alva Bianchi, Andrés J. Muñoz Martín, Gabriela Torres Pérez-Solero, Laura Ortega, Aitana Calvo Ferrándiz, Juan Luis Catoya Villa, Marta Arregui Valles, Inmaculada Aparicio Salcedo, Miguel Martin
Publikováno v:
Journal of Clinical Oncology. 40:e15552-e15552
e15552 Background: BRAF mutated mCRC patients have worse prognosis compared with BRAF wildtype mCRC. Within this group, those with resectable disease have a better prognosis compared to those with unresectable disease. However, it is not well known w
Autor:
Andres J. Muñoz Martín, Javier Soto Alsar, Gabriela Torres Pérez-Solero, Pilar García-Alfonso, Javier Parrondo
Publikováno v:
Clinical Case Reports and Reviews. 7
Autor:
Laura Ortega Morán, Pilar Aitana Calvo Ferrandiz, Gabriela Torres Pérez-Solero, Pilar García-Alfonso, Montserrat Blanco Codesido, Andres J. Muñoz Martín, Silvina Grasso Cicala, Javier Soto Alsar
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Colorectal cancer (CRC) is one of the most common forms of cancer, with an estimated 1.36 million new cases and almost 700,000 deaths annually. Approximately 21% of patients with CRC have metastatic disease at diagnosis. The objective of this article
Autor:
Andrés J. Muñoz Martín, Laura Ortega Morán, Natalia Gutiérrez Alonso, Diego Megias, Ana Lopez-Alfonso, Maria del Monte Millán, Rebeca Bernat, Rocío Martín Lozano, Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Lucía Villarejo López, Tatiana Massarrah, Gabriela Torres Pérez-Solero, Aitana Calvo Ferrándiz, Montserrat Blanco-Codesido, Pilar Garcia-Alfonso, Miguel Martin
Publikováno v:
Journal of Clinical Oncology. 40:586-586
586 Background: In recent years CTCs have been extensively studied in different neoplasms. However, in PC CTCs are still emerging as a potential prognostic tool and the significance in different stages of the disease and the correlation with tumor ma
Autor:
Javier Soto, Natalia Gutiérrez Alonso, Marianela Bringas Beranek, Juan Luis Catoya Villa, Ana Gutierrez Ortiz de la Tabla, Carlos López Jiménez, Manuel Alva Bianchi, Roberto Jiménez Rodríguez, Rocío Martín Lozano, Marta Arregui Valles, Inmaculada Aparicio Salcedo, Laura Ortega Morán, Gabriela Torres Pérez-Solero, Andrés J. Muñoz Martín, Aitana Calvo Ferrándiz, Montserrat Blanco Codesido, Íñigo Martínez Delfrade, David Salomon Juliao Caamaño, Miguel Martin, Pilar Garcia-Alfonso
Publikováno v:
Journal of Clinical Oncology. 40:59-59
59 Background: Over the last decades the incidence of EOCRC (age 50 or less) has dramatically increased, and so has the scientific interest in this field, given that clinical and molecular characteristics in these patients are not well understood, an